21 August 2024 | News
To complement existing research programmes and collaborations in drug discovery and organoid innovation
That’s where the Faculty of Medicine and Health’s newly established Biomanufacturing Incubator comes into play. It is a multidisciplinary initiative that aims to unify areas around the University of Sydney already independently working in the field, led by Professor Steven Wise, cardiovascular bioengineering researcher and a National Heart Foundation Future Leader Fellow, and Associate Professor Khoon Lim, biomedicine researcher and Australian Research Council Future Fellow.
Currently, industry practice is to have companies make and sell 3D bioprinters to individual researchers or labs, who conduct their research in silos. Professor Wise says this is what’s holding back progress.
“There’s little translation of this research into commercialisation,” says Professor Wise from the School of Medical Sciences.
The Biomanufacturing Incubator adds another important element to the University’s strength in this area. It will complement existing research programmes and collaborations in drug discovery and organoid innovation, and core research facilities such as Sydney Analytical.